Marciela Scarpellini

Synthesis, structure, and physicochemical properties of dinuclear NiII complexes as highly efficient functional models of phosphohydrolases.

As metal ions are present in the catalytic sites of several enzymes, attention has been focused on the synthesis and characterization of metal complexes able to act as biomimetic functional and structural models for these systems. In this study, a novel dinuclear NiII complex was synthesized, [Ni2(L2)(OAc)2(CH3CN)]BPh4 (2) (HL2=2-[N-(2-(pyridyl-2-yl)ethyl)(1-methylimidazol-2-yl)amin omethyl]-4-methyl-6-[N-(2-(imidazol-4-yl)ethyl)amino methyl]phenol), employing a new unsymmetrical dinucleating ligand containing N,O-donor groups as a model for hydrolases. Complex 2 was characterized by a variety of techniques including: elemental analysis, infrared and UV-vis spectroscopies, molar conductivity, electrochemistry, potentiometric titration, magnetochemistry, and single-crystal X-ray diffractometry. The structural and magnetochemical data of 2 allow us to consider this complex as a structural model for the active site of the ureases, as previously reported for [Ni2(L1)(OAc)2(H2O)]ClO4.H2O (1) (HL1=2-[N-bis-(2-pyridylmethyl)aminomethyl]-4-methyl-6-[N-(2-pyridylmethyl)aminomethyl] phenol). The characterization of complexes 1 and 2 (mainly by X-ray diffraction and potentiometric titration) led us to study their reactivities toward the hydrolysis of the substrate bis(2,4-dinitrophenyl)phosphate (2,4-BDNPP). These studies revealed that complexes 1 and 2 show the best catalytic activity reported so far, with acceleration rates 8.8x10(4) and 9.95x10(5) times faster, respectively, than the uncatalyzed hydrolysis of 2,4-BDNPP. Catalytic activity of 2 on 2,4-DNPP showed that the monoester is hydrolyzed 27 times slower than the 2,4-BDNPP diester under identical experimental conditions. Therefore, 1 and 2 can undoubtedly be considered highly efficient functional models of the phosphohydrolases.

Mononuclear CuII−Phenolate Bioinspired Complex is Catalytically Promiscuous: Phosphodiester and Peptide Amide Bond Cleavage

In this work, the cleavage activity of the metal complex [Cu(C(21)H(21)N(3)O(2))(OH(2))(2)](2+) is demonstrated to occur toward double-stranded DNA, in addition to its previously described amide bond cleavage activity, thus suggesting catalytic promiscuity for this complex.

A new oxo-vanadium complex employing an imidazole-rich tripodal ligand: a bioinspired bromide and hydrocarbon oxidation catalyst.

A vanadyl complex with the ligand (bis(1-methylimidazol-2-yl)methyl)(2-(pyridyl-2-yl)ethyl)amine was synthesized and fully characterized by X-ray crystallography, elemental analyses, cyclic voltammetry and infrared, electronic and electron paramagnetic resonance spectroscopies. This compound was designed under the so called hybrid concept. It shows to be able to promiscuously use hydrogen peroxide to oxidize bromide and to catalyze the oxidation of benzene and cyclohexane with very good selectivities.

Synthesis, characterization and biological activities of mononuclear Co(III) complexes as potential bioreductively activated prodrugs.

Aiming to investigate the use of tridentate ligands to develop new bireductively activated prodrugs, two N(2)O-donor ligands (HL1: [(2-hydroxybenzyl)(2-(imidazol-2-yl)ethyl)]amine; and HL2: [(2-hydroxybenzyl)(2-(pyridil-2-yl)ethyl]amine) were used to synthesize new Co(III) complexes, 1 and 2. Both complexes were characterized by X-ray crystallography, mass spectrometry, electrochemistry, IR, UV-visible and (1)H NMR spectroscopies. Electrochemical data in methanol revealed that the Co(III)-->Co(II) reduction of 1 (-0.84V vs. normal hydrogen electrode - NHE) is more positive than 2 (-1.13V vs. NHE), while it was expected to be more negative due to better sigma-donor ability of imidazole ring in HL1, compared to pyridine in HL2. Considering that reduction processes on Co(III) center may involve the lowest unoccupied molecular orbital (LUMO), it might play an important role on the electronic properties of the complexes, and could explain the observed redox potentials. Then, geometry optimizations of 1 and 2 were performed using the density functional theory (DFT), and different group participation in their LUMO is demonstrated. Using Saccharomyces cerevisiae cells as eukaryotic model, it is shown that in situ generated reduced species, 1(red) and 2(red), have high capacity to inhibit cellular growth, with IC50 (0.50mM for both complexes) lower than cisplatin IC50 (0.6mM) at the same time of exposure. Regarding to their ability to promote S. cerevisiae cells death, after 24 h, cells became susceptible only when exposed to 1(red) and 2(red): (i) at concentrations higher than 0.5mM in a non-dose dependence, and (ii) in anaerobic metabolism. These data reveal the potential of 1 and 2 as bioreductively activated prodrugs, since their oxidized forms do not present expressive activities when compared to their reduced forms.

Azido- and chlorido-cobalt complex as carrier-prototypes for antitumoral prodrugs.

Cobalt(III) complexes are well-suited systems for cytotoxic drug release under hypoxic conditions. Here, we investigate the effect of cytotoxic azide release by cobalt-containing carrier-prototypes for antitumoral prodrugs. In addition, we study the species formed after reduction of Co(3+) → Co(2+) in the proposed models for these prodrugs. Three new complexes, [Co(III)(L)(N3)2]BF4(1), [{Co(II)(L)(N3)}2](ClO4)2(2), and [Co(II)(L)Cl]PF6(3), L=[(bis(1-methylimidazol-2-yl)methyl)(2-(pyridyl-2-yl)ethyl)amine], were synthesized and studied by several spectroscopic, spectrometric, electrochemical, and crystallographic methods. Reactivity and spectroscopic data reveal that complex 1 is able to release N3(-) either after reduction with ascorbic acid, or by ambient light irradiation, in aqueous phosphate buffer (pH6.2, 7.0 and 7.4) and acetonitrile solutions. The antitumoral activities of compounds 1-3 were tested in normoxia on MCF-7 (human breast adenocarcinoma), PC-3 (human prostate) and A-549 (human lung adenocarcinoma epithelial) cell lines, after 24h of exposure. Either complexes or NaN3 presented IC50 values higher than 200 μM, showing lower cytotoxicity than the clinical standard antitumoral complex cisplatin, under the same conditions. Complexes 1-3 were also evaluated in hypoxia on A-549 and results indicate high IC50 data (>200 μM) after 24h of exposure. However, an increase of cancer cell susceptibility to 1 and 2 was observed at 300 μM. Regarding complex 3, no cytotoxic activity was observed in the same conditions. The data presented here indicate that the tridentate ligand L is able to stabilize both oxidation states of cobalt (+3 and +2). In addition, the cobalt(III) complex generates the low cytotoxic cobalt(II) species after reduction, which supports their use as as carrier prototypes for antitumoral prodrugs.

Synthesis, characterization and catalytic activity of two novel cis-dioxovanadium(v) complexes: [VO2(L)] and [VO2(Hlox)]

respectively, in a distorted octahedral environment. The catalytic activity of these compounds towards cyclohexane oxidation was evaluated using H2O2 and t-BuOOH as oxidants. Both complexes presented > 70% selectivity for cyclohexylhydroperoxide formation. B3LYP/6-31G(d) calculations were used to confirm the geometry and to help assign the electronic spectra.

Binuclear CuII complexes as catalysts for hydrocarbon and catechol oxidation reactions with hydrogen peroxide and molecular oxygen

The tridentate ligands HL1, [(2-hydroxybenzyl)(2-(imidazol-2-yl)ethyl)]amine, and HL2, [(2-hydroxybenzyl)(2-(pyridil-2-yl)ethyl]amine, were used to synthesize binuclear CuII complexes, [Cu2(L1)2]Cl2•2H2O, complex 1, and [Cu2(L2)2](ClO4)2•1.5H2O, complex 2, in order to obtain catalysts for oxidative processes. Both complexes were characterized by elemental analysis, IR, UV-Vis and EPR spectroscopies. In addition, they were studied by cyclic voltammetry and potentiometric titration in order to investigate their behavior in solution. The crystal structure of complex 1 revealed a binuclear cation where the metal centers are bridged by two phenoxo groups. This arrangement provides a Cu...Cu distance of 3.043(10) A, which is similar to the observed for catechol oxidase (2.90 A). The catalytic reactivities of both complexes were investigated for hydrocarbon and catechol oxidations. Complexes 1 and 2 led to low overall hydrocarbon oxidation conversion values of 6.34 % and 7.15 %, respectively. However, for complex 1, only cyclohexanol (Cy-OH) and cyclohexanone (Cy=O) were isolated as reaction products, with selectivities of 68.1% for Cy-OH. This low overall conversion is tentatively attributed to steric hindrance effects produced by the non-coplanar aromatic rings of the ligand scaffolds, which suggest that the access of the hydrocarbon molecule to the binuclear active center is a determinant step in the reaction mechanism. Investigation of catecholase activities has shown high efficiencies, with complex 2 being more active than complex 1. It indicates that the pyridine-containing ligand is able to stabilize the intermediate CuICuI center which is proposed to be formed in this process. This is corroborated by the strong participation of pyridine in the LUMO (lowest unoccupied molecular orbital) of complex 2, which can help to accommodate the additional negative charge when the complex is reduced from CuIICuII to CuICuI.

A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: Chemical properties and cytotoxicity activity

Continuing our interest in tridentate ligands to develop new prototypes of cobalt-based metallodrugs for combating cancer, modifications in the backbone of HL1, [(2-hydroxybenzyl)(2-(pyridil-2-yl)ethyl]amine) were proposed in order to modulate the redox potential of new Co(III) complexes. Three ligands with electron withdrawing groups were synthesized: HL2: [(2-hydroxy-5-nitrobenzyl)(2-(pyridil-2-yl)ethyl]amine); HL3: [(2-hydroxybenzyl)(2-(pyridil-2-yl)ethyl]imine) and HL4: [(2-hydroxy-5-nitrobenzyl)(2-(pyridil-2-yl)ethyl]imine). They were used to obtain the respective mononuclear complexes 2, 3 and 4, which are discussed compared to the previous reported complex 1 (obtained from HL1). The new complexes were characterized and studied by several techniques including X-ray crystallography, elemental and conductimetric analysis, IR, UV-vis and (1)H NMR spectroscopies, and electrochemistry. The substitutions of the group in the para position of the phenol (HL1 and HL2) and the imine instead of the amine (HL3 and HL4), promote anodic shifts in the complexes reduction potentials. The influence of these substitutions in the biological activities of the Co(III) complexes against the murine melanoma cell line (B16F10) was also evaluated. Little effect was observed on cellular viability decrease for all free ligands, however the coordination to Co(III) enhances their activities in the following range: 1>4≈2>3. The data suggest that no straight correlation can be addressed between the reduction potential of the Co(III) center and the cell viability.

Copper Complexes as Bioinspired Models for Lytic Polysaccharide Monooxygenases

We report here two copper complexes as first functional models for lytic polysaccharide monooxygenases, mononuclear copper-containing enzymes involved in recalcitrant polysaccharide breakdown. These complexes feature structural and spectroscopic properties similar to those of the enzyme. In addition, they catalyze oxidative cleavage of the model substrate p-nitrophenyl-β-d-glucopyranoside. More importantly, a particularly stable copper(II) hydroperoxide intermediate is detected in the reaction conditions.

Estudo espectroscópico de compósito obtido da reação no estado sólido entre um complexo mononuclear de vanádio(IV) e caulinita

The use of probes, such as paramagnetic species diluted in diamagnetic materials in EPR spectroscopy, and mathematical tools such, as the Kubelka-Munk function in DRUV-VIS spectroscopy are strategies in the analysis of complex mixtures of solid materials. The results obtained here show that the solid state reaction between the complex, [VO(acac)(BMIMAPY)] [ClO4], BMIMAPY = [(bis(1-methylimidazole-2-yl)methyl)(2-(pyridyl-2-yl)ethyl) amine] and acac = acetilacetonate, with kaolinite turns possible to obtain anisotropic EPR spectrum of the complex with a reasonable level of resolution. The study by DRUV-VIS using the method of second derivative mode of the Kubelka-Munk function revealed new complex structural arrangements, a solid hitherto unknown.